Position in GSK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$8,596
New position
Shares Held
164
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#938
of 1,033 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Oakmont Advisory Group, LLC holds $1,573,119 across 11 Drug Manufacturers - General names. GSK ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
348 | $417,401 | |
| 2 | JNJ |
Johnson & Johnson
|
1,565 | $397,463 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,005 | $386,142 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,639 | $333,411 | |
| 5 | AMGN |
Amgen Inc
|
45 | $16,295 | |
| 6 | ABBV |
AbbVie Inc.
|
45 | $11,323 | |
| 7 | GSK |
GSK plc
This page
|
164 | $8,596 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39 | $2,247 |
All Filings in GSK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,596 | 164 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||